0000899243-21-016871.txt : 20210423
0000899243-21-016871.hdr.sgml : 20210423
20210423165130
ACCESSION NUMBER: 0000899243-21-016871
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210415
FILED AS OF DATE: 20210423
DATE AS OF CHANGE: 20210423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hashemi Hutan
CENTRAL INDEX KEY: 0001849054
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39334
FILM NUMBER: 21850485
MAIL ADDRESS:
STREET 1: 4330 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENITY, INC.
CENTRAL INDEX KEY: 0001580063
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 273950390
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4330 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 855-293-2639
MAIL ADDRESS:
STREET 1: 4330 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: ASCENDANT MDX, INC.
DATE OF NAME CHANGE: 20130625
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-04-15
2021-04-19
0
0001580063
PROGENITY, INC.
PROG
0001849054
Hashemi Hutan
C/O PROGENITY, INC.
4330 LA JOLLA VILLAGE DRIVE, SUITE 200
SAN DIEGO
CA
92122
0
1
0
0
Chief Compliance Officer
Common Stock
2021-04-15
4
A
0
11494
0.00
A
22667
D
Stock Option (Right to Buy)
3.41
2021-04-15
4
A
0
24114
0.00
A
2031-04-15
Common Stock
24114
24114
D
Consists of 11,494 restricted stock units, 25% of which will vest on May 15, 2022, with the remaining shares vesting in equal semi-annual installments through May 15, 2025, subject to the Reporting Person's continued
service to the Issuer.
The Reporting Person's Form 4 filed on April 19, 2021 inadvertently omitted from the total amount of securities beneficially owned following the transaction 11,173 shares previously reported on the Reporting Person's Form 3 filed on March 15, 2021.
This option represents the right to purchase 24,114 shares of the Issuer's common stock, 502 of which vested upon grant, with the remaining shares vesting in equal monthly installments through March 15, 2025, subject
to the Reporting Person's continued service to the Issuer.
/s/ Will Pridgen, Attorney-in-Fact for Hutan Hashemi
2021-04-23